Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-27 @ 2:09 AM
Study NCT ID:
NCT01413893
Status:
COMPLETED
Last Update Posted:
2017-11-21
First Post:
2011-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors
Sponsor:
AbbVie
Organization:
Study Overview
Official Title:
An Extension Study of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
Status:
COMPLETED
Status Verified Date:
2012-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An extension study of linifanib in subjects with advanced or metastatic solid tumors.
Detailed Description:
This study is designed to evaluate the safety of linifanib in subjects with advanced or metastatic solid tumors.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: